AAKG (Arginine Alpha-Ketoglutarate).

Citrulline is converted to arginine in the kidney and escapes the intestinal arginase that clears much of an oral arginine dose. The pair raises and then holds the same arginine pool.

Arginine and lysine share the y+ transporter family, so a substantial lysine dose reduces arginine uptake. The competition is settled transport pharmacology.

Alpha-ketoglutarate is aminated to glutamate and then to glutamine, the body's main nitrogen carrier. The AKG half of this compound enters the same pathway glutamine sits in.

Prolyl and lysyl hydroxylases consume alpha-ketoglutarate and depend on ascorbate to keep their iron centre reduced, so both parts of this pairing appear in one reaction. Ascorbate also protects the tetrahydrobiopterin that keeps nitric oxide synthase coupled to arginine.

Alpha-ketoglutarate dependent dioxygenases all carry a ferrous iron centre. Iron status decides whether the AKG half can be used in hydroxylation reactions.

Collagen peptides supply the proline, glycine and hydroxyproline building blocks, while alpha-ketoglutarate is the co-substrate the hydroxylases need to stabilise the triple helix. The pairing covers material and reaction in one place.

Arginase converts arginine to ornithine and urea, so ornithine is the immediate downstream product. Both intermediates support normal ammonia handling.

Arginine donates its amidino group to glycine to begin creatine synthesis, so it is an upstream precursor of creatine. Supplying creatine directly spares arginine for nitric oxide and urea cycle duty.

Nitrate reduction makes nitric oxide without any enzyme substrate while arginine works through nitric oxide synthase. Neither route depends on the other.

Kaczka and colleagues gave beta-hydroxy-beta-methylbutyrate together with L-arginine alpha-ketoglutarate and measured jump performance in young athletes, so this pairing has been studied as a combination rather than inferred. The two act by unrelated routes, HMB on muscle protein turnover and arginine on nitric oxide substrate supply. Read the result as a single trial in a specific athletic population.

Alpha-ketoglutarate is oxidised in the citric acid cycle by the alpha-ketoglutarate dehydrogenase complex, and the E2 subunit of that complex carries a lipoamide arm that shuttles the acyl group. That makes lipoic acid a structural part of the machinery handling the AKG half of this salt. The cofactor relationship is textbook; it is not a claim that supplemental lipoic acid increases AKG oxidation.

The decarboxylation of alpha-ketoglutarate requires thiamine pyrophosphate at the E1 subunit. Without adequate thiamine that step slows and alpha-keto acids accumulate, which is settled biochemistry. Any formula supplying alpha-ketoglutarate for energetic reasons is operating downstream of thiamine status.

Dihydrolipoyl dehydrogenase, the E3 component, uses FAD derived from riboflavin to reoxidise the lipoamide arm. Riboflavin therefore sits in the same catalytic cycle as thiamine and lipoic acid for this reaction. It is one of the four vitamin dependencies of a single enzyme complex.

The alpha-ketoglutarate dehydrogenase reaction reduces NAD+ to NADH, so niacin-derived NAD+ is the terminal acceptor for that step. NAD+ availability is what couples the reaction to mitochondrial respiration. Established bioenergetics, not an effect measured for the salt.

The product of alpha-ketoglutarate oxidation is succinyl-CoA, which means coenzyme A, built from pantothenate, is a required substrate. Pantothenate status therefore constrains the same step as thiamine and riboflavin. This completes the cofactor picture around the AKG moiety.

Nicotinamide riboside raises cellular NAD+ through the nicotinamide riboside kinase route, and NAD+ is the acceptor for alpha-ketoglutarate oxidation. The connection is real at the pathway level. Whether raising NAD+ changes anything measurable about how supplemental alpha-ketoglutarate is used has not been shown.

Oral arginine is heavily degraded by arginase in the intestine and liver before it reaches the circulation, and arginase carries two manganese ions in its active site. That first-pass loss is the main reason a given oral arginine dose raises plasma arginine less than expected. The manganese link is enzymology, and it points at a limit on the ingredient rather than an enhancement.

L-arginine:glycine amidinotransferase transfers the amidino group of arginine onto glycine to form guanidinoacetate, the creatine precursor. Arginine supply is therefore an input to the body's own creatine synthesis as well as to nitric oxide production. The pathway is settled; how much a supplemental arginine dose shifts creatine synthesis is another question.

Arginase releases ornithine, which ornithine aminotransferase and pyrroline-5-carboxylate reductase carry forward to proline, the residue collagen is built on. That is why arginine appears in tissue-repair formulas next to proline and vitamin C. The conversion is established metabolism; it is not a claim about wound outcomes.

The step that moves ornithine toward proline and glutamate requires pyridoxal-5-phosphate. B6 status therefore sits inside the arginine to proline route. Standard transaminase biochemistry.

Argininosuccinate synthetase and the creatine kinase reaction both act on magnesium-bound ATP, and mitochondrial substrate-level phosphorylation from succinyl-CoA does too. Magnesium is a general requirement rather than a specific partner, which is exactly why it gets left out. Stated here for completeness.

Beta-alanine raises intramuscular carnosine over weeks and buffers protons during high-intensity work, a chronic mechanism unrelated to acute nitric oxide substrate supply. Stacking covers two different limiters. The combination is a formulation convention rather than a measured pairing here.

Bicarbonate raises extracellular buffering capacity for high-intensity efforts, where an arginine salt is aimed at vascular substrate supply. Adding them targets different constraints. Gastrointestinal tolerance is the practical limit on bicarbonate, not any interaction with arginine.

Pine bark polyphenols are formulated for endothelial nitric oxide reasons, and arginine is offered as the substrate for nitric oxide synthase, so the two are combined on complementary logic. The additive direction is plausible and unmeasured together here. Anyone whose blood pressure is medically managed should count both.

Garlic preparations have a modest documented influence on blood pressure, and arginine is supplied as a nitric oxide substrate, so a stack pushes vascular tone the same way through different routes. This is a flag about additivity, not a claim of benefit. It matters most for people already on blood pressure medication, who need their clinician in the loop.

A standard whey serving contains several hundred milligrams of arginine as part of its amino acid profile, so a protein-plus-AAKG stack delivers arginine from two sources. Bolus amino acid loads also compete for the same cationic amino acid transporters. The practical point is that free arginine dosing sits on top of a dietary baseline that is rarely counted.

HMB is formed from leucine by way of alpha-ketoisocaproate, which is the metabolic link to the one AAKG combination that has been studied here. Leucine and arginine also share transport into muscle as substrates of different systems. The precursor relationship is settled biochemistry.